PubMed Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, et al
Dr Max Taquet, Clinical Lecturer at the University of Oxford and senior author of the study, added: Our study is observational and these results should therefore be replicated in a randomised controlled trial to confirm and extend our findings. Nevertheless, they are good news for patients with psychiatric disorders, who are at an increased risk of diabetes. While semaglutide is also used in people with obesity, with most diabetes patients with type 2 diabetes also presenting being overweight or obese, the findings from this study cannot be applied to people who do not have diabetes.
ROS has long been recognized as a harmful substance, and its excessive accumulation will cause the release of inflammatory factors, enhance the adhesion of inflammatory factors to endothelial cells, and promote apoptosis and even cause cell death (Forrester et al., 2018)
Peptides for weight loss offer intriguing possibilities in the quest for effective weight loss solutions, but they should also be considered as a part of a broader approach that includes a balanced diet and regular physical activity
Maintenance treatment: 1 session every 3 months
